发明名称 CALCIUM RECEPTOR-ACTIVE COMPOUNDS
摘要 <p><P>PROBLEM TO BE SOLVED: To provide new inorganic ion receptor-active compounds. <P>SOLUTION: The compounds having formula: Ar<SB>1</SB>-CO-[CH<SB>2</SB>]<SB>q</SB>-NH-CHCH<SB>3</SB>-Ar<SB>2</SB>[Ar<SB>1</SB>is selected from the group consisting of dibenzylamino, benzyl(naphthylmethyl)amino, benzyl(pyridiylmethyl)amino, benzyl(piperonyl)amino and benzyl(thienylmethyl)amino; Ar<SB>2</SB>is naphthyl], or the pharmaceutically acceptable salts or hydrates of the compounds. In addition, a composition for treating or preventing a disease selected from the group consisting of hyperparathyroidism, renal osteodystrophy, hypercalcemia accompanied with malignant tumors, osteoporosis, Paget's disease, and hypertension. <P>COPYRIGHT: (C)2007,JPO&INPIT</p>
申请公布号 JP2007153904(A) 申请公布日期 2007.06.21
申请号 JP20070003556 申请日期 2007.01.11
申请人 KIRIN BREWERY CO LTD;NPS PHARMACEUT INC 发明人 SAKAI TERUYUKI;TAKAMI ATSUYA;SUZUKI RIKA
分类号 C07C211/30;A61K31/137;A61K31/138;A61K31/165;A61K31/341;A61K31/343;A61K31/352;A61K31/36;A61K31/381;A61K31/40;A61K31/403;A61K31/4035;A61K31/404;A61K31/4045;A61K31/423;A61K31/426;A61K31/428;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/47;A61K31/4965;A61K31/554;A61P3/14;A61P5/18;A61P5/20;A61P9/12;A61P19/08;A61P19/10;A61P43/00;C07C217/12;C07C217/16;C07C217/20;C07C217/24;C07C217/58;C07C217/62;C07C237/06;C07C237/08;C07C237/10;C07C317/18;C07C317/28;C07C323/25;C07C323/41;C07D207/32;C07D207/335;C07D209/08;C07D209/14;C07D209/44;C07D209/88;C07D213/38;C07D213/40;C07D213/70;C07D215/36;C07D241/12;C07D263/58;C07D277/28;C07D277/74;C07D281/06;C07D281/10;C07D307/52;C07D307/91;C07D311/30;C07D317/58;C07D333/20;C07D333/34 主分类号 C07C211/30
代理机构 代理人
主权项
地址